This HTML5 document contains 109 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1517/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q56909272
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel наукова стаття, опублікована у квітні 2008 im April 2008 veröffentlichter wissenschaftlicher Artikel scholarly article by Stephen K Field published 30 April 2008 in Expert Opinion on Investigational Drugs
p:P577
wds:Q56909272-8F51C3CB-FD36-49A3-9589-DDD3B61C68B8
wdt:P577
2008-04-30T00:00:00Z
p:P407
wds:Q56909272-A5C13B1E-2BA4-40D8-B86C-977ECD87E941
wdt:P407
wd:Q1860
p:P2860
wds:Q56909272-365A0CE8-DF29-4A6B-B9F5-CC221FFC3AD6 wds:Q56909272-4BFD79C2-FEAC-4B8D-9DB7-E1D00B5B1459 wds:Q56909272-55B43C76-6A97-4F4E-A7CD-ABF2D1B22BF5 wds:Q56909272-575A492C-8057-4881-8F53-B4ECF4C4FF61 wds:Q56909272-21E04F50-32D5-46C7-9458-5627385B9E80 wds:Q56909272-2296D731-E060-4190-9F4C-495764E7D80A wds:Q56909272-356A6B2D-018B-41C0-B2BB-CBE86DEE548B wds:Q56909272-356E1B5C-A119-4B5A-BD9C-F2EC91355CF2 wds:Q56909272-72E07A65-5F07-4642-9ABD-44C59BD28A54 wds:Q56909272-81EE9255-5E19-492C-A96C-E1837B16777D wds:Q56909272-84C9FEBA-D77C-4254-8A1E-7B464FDE8BF8 wds:Q56909272-5CCC9AF8-612B-44AF-A0A2-CFCE758A1F7C wds:Q56909272-5FDCB6B5-2624-4554-AF11-B8AB9B03982B wds:Q56909272-61DBAC23-D299-4F1D-B98D-CCA390A05A46 wds:Q56909272-67818D86-34AC-414A-BD3E-35BDFA77930C wds:Q56909272-92A1AA31-5E88-4CCA-A0B8-31ADA651540D wds:Q56909272-A4F9327B-00A2-446F-BE24-4B1D74B4E62C wds:Q56909272-9192FFA3-2C08-4C93-852E-ABFAC01C7500 wds:Q56909272-920A136A-4A59-448F-A386-DD504EBAA8AA wds:Q56909272-CBFBE7AF-D306-42A6-B30E-1F6FC542067A wds:Q56909272-D0A204C1-CF16-4449-8DB0-FA98F40FD3B9 wds:Q56909272-A93A76C8-06E5-4BCB-BCE1-8D5CE89081E4 wds:Q56909272-AFC1B5A4-3DFE-4A72-93CC-D21106AA3727 wds:Q56909272-BEEFF67C-1224-4111-B59D-6107DEB02159 wds:Q56909272-01013110-A9F7-4107-AEA7-39E6D17C2C5E wds:Q56909272-0F327D34-603E-422A-AAFE-360334F04BB4 wds:Q56909272-17A74B10-CF2F-4215-BDA6-850BF4B96CBC wds:Q56909272-DDD06FBB-70D3-4C9C-B914-351C4B3BC827 wds:Q56909272-E36DFD25-28A7-49EC-815E-FF3459F8E785 wds:Q56909272-F4DF7AEE-1BEB-400A-A5A3-C542A22DAAEB wds:Q56909272-D19A59DC-4CB3-4E33-A513-E1DB0A4E58BE wds:Q56909272-D3262870-644F-4A0B-AC33-78321869C2DE wds:Q56909272-F5A816D5-75B4-4A65-9986-F93208A70CE1 wds:Q56909272-FD159F8F-B27B-4EA9-A973-AF642ED27DA4
wdt:P2860
wd:Q42612610 wd:Q36945368 wd:Q46647320 wd:Q46781100 wd:Q28296195 wd:Q53511586 wd:Q35080486 wd:Q42644990 wd:Q36169173 wd:Q39322017 wd:Q36236845 wd:Q44863693 wd:Q29618682 wd:Q41708863 wd:Q51103821 wd:Q35869635 wd:Q58877159 wd:Q35534841 wd:Q36496374 wd:Q51712216 wd:Q42764447 wd:Q43897053 wd:Q46637522 wd:Q36945365 wd:Q46649423 wd:Q35592380 wd:Q36003459 wd:Q46551607 wd:Q29618681 wd:Q35768809 wd:Q51489355 wd:Q46966092 wd:Q47858987 wd:Q40682613
rdfs:label
Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma
skos:prefLabel
Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma
schema:name
Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma
p:P50
wds:Q56909272-852F36E1-7000-4F1B-8941-385B8E0FD822
wdt:P50
wd:Q41118828
p:P1476
wds:Q56909272-F1B29D58-446C-45E9-9142-E07AB0D175B1
wdt:P1476
Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma
p:P304
wds:Q56909272-9936F58C-E8FC-4B52-B2B0-D5CA196C1F39
wdt:P304
811-818
p:P31
wds:Q56909272-e2792be5-02c7-47a8-a57e-73eb1e5fb427 wds:Q56909272-C587062E-E4F1-45B1-8DF5-257BE8179687
wdt:P31
wd:Q7318358 wd:Q13442814
p:P921
wds:Q56909272-C3550F28-0AEB-45AB-975C-DED5E87F5396 wds:Q56909272-68645690-8876-4AF6-B8EE-B6B7E675EA95
wdt:P921
wd:Q35869 wd:Q199804
p:P698
wds:Q56909272-FD4871CC-09BF-4043-BF5A-5A534EBA4ACD
wdtn:P698
n9:18447606
wdt:P698
18447606
p:P1433
wds:Q56909272-D74686F5-1D76-40EF-BD66-F6979891131C
wdt:P1433
wd:Q5421208
p:P433
wds:Q56909272-B12806DC-3A1C-4D03-9E45-74AC50C3C9BC
p:P478
wds:Q56909272-DDC4AEA3-6FD9-4A24-A2D1-D7C2FDFBE162
wdt:P433
5
wdt:P478
17
p:P356
wds:Q56909272-1A2236F3-EF00-4C29-8E59-2998BC809702
wdtn:P356
n12:13543784.17.5.811
wdt:P356
10.1517/13543784.17.5.811